Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of…

By M. Rybak, B. Lomaestro, J. Rotschafer, R. Moellering, W. Craig, M. Billeter, J. Dalovisio, D. Levine. Clinical Infectious Diseases, 2009

816 citations recorded by the source corpus.

Subfields: Clinical Biochemistry, Infectious Diseases, Pharmacology

View Paper: https://www.semanticscholar.org/paper/b5a1339591b5852af0e885c4251cf320555926a2

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Clinical Biochemistry

1. D. Levine
2. Robert S. Daum
3. S. Cosgrove

In Infectious Diseases

1. D. Levine
2. Robert S. Daum
3. S. Cosgrove
4. Henry F. Chambers

In Pharmacology

1. D. Levine

Citations in the corpus

• Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. (2011, background): “What are the recommendations for vancomycin dosing and monitoring? These recommendations are based on a consensus statement of the American Society of Health-System Pharmacists, the IDSA, and The Society of Infectious Diseases Pharmacists on guidelines for vancomycin dosing [3, 4].”